- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2006
- Public Summary Document (PSD) March 2006 PBAC Meeting - PDF
Erlotinib hydrochloride – March 2006
Erlotinib hydrochloride, tablet, 25 mg, 100 mg and 150 mg (base), Tarceva®
Last updated
14 July 2006